New Cambridge business targets accurate oxygen delivery and other medical markets
An exciting new UK MedTech company, launched today in Cambridge, is set to revolutionise fluid control in the healthcare and life sciences industries with a unique, energy-recycling valve technology.
The vision for Camcon Medical is to provide solutions for areas of substantial unmet medical need.
The innovative technology was invented by Wladyslaw Wygnanski, who is a director at Camcon Medical.
The unique, patented technology has had proven success in the oil and gas and automotive industries and is felt to have huge potential to succeed in the healthcare and life sciences sectors.
Camcon Medical is the latest company to launch within the Camcon Federation of companies – all founded in Cambridge.
By utilising the patented Binary Actuation Technology (BAT), Camcon Medical plans to enhance the performance of existing products and create new innovations across multiple applications that require precise gas and liquid flow control.
The first venture for the business is in the medical devices market with a focus on respiratory care and oxygen delivery.
Already at prototype stage the company hopes to collaborate with partners to bring it to market, but this is only the beginning! Camcon Medical also aims to expand the application of the technology into implantable devices, mechanical aids – for example, prosthetics – and precision lab dispensing.
The company’s intention is to work closely with leading clinicians, industry organisations or individual partners on each innovation programme.
Oxygen delivery was identified as one of its first applications because accurate dosing is a substantial clinical challenge – especially as over or under dosing of oxygen can be fatal. An estimated 2,000 to 4,000 patients a year in the UK die from incorrect oxygen supply.
Charles Potter, director at Camcon Medical explains: “Patient safety and quality of life are key for people who require oxygen therapy, whether within the home or clinical environment, which is where BAT can provide substantial benefits.
“The accurate dosage provided through our intelligent and silent valve technology can also reduce wastage, providing greater cost efficiencies, which is extremely important, as currently £34million is spent each year in the UK on wasted oxygen.
“We believe that with our technology we can deliver true innovation within this market, demonstrating the three dimensions of value that are critical in healthcare, including clinical benefit, patient quality of life and economic value.”
First invented in 1998 by Wladyslaw Wygnanski, BAT is a fail-safe and pioneering technology that allows a valve to switch between its open and closed status faster than any other valve mechanisms, all while using a miniscule amount of energy, resulting in major breakthroughs across an array of industry challenges and markets.
The move into healthcare and life sciences follows on from BAT’s proven success and established heritage in the oil and gas and automotive industries.
Wygnanski says: “The secret to BAT’s years of success is its versatility. While our initial efforts are focused on medical devices, this is just the beginning.
“We are also looking at opportunities within three additional areas where BAT can be applied. These include implantable devices within the human body, mechanical aids, such as prosthetics and blood circulation support and accurate laboratory dispensing equipment, which can also be applied to drug dosing and delivery.
“We are reviewing the opportunities within these markets and are keen to invite potential partners to collaborate with us on enhancing their own products, developing our initial concepts and creating new innovations.”
• PHOTOGRAPH SHOWS: Wladyslaw Wygnanski